"10.1371_journal.pone.0137871","plos one","2015-09-14T00:00:00Z","Kiran Kumar Jagarlamudi; Laura Moreau; Sara Westberg; Henrik RÃ¶nnberg; Staffan Eriksson","Department of Anatomy, Physiology, and Biochemistry, Veterinary Medicine and Animal Science center, Swedish University of Agricultural Sciences, Uppsala, Sweden; University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala, Sweden; Center of Clinical Comparative Oncology (C3O), Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden","Conceived and designed the experiments: KK HR SE. Performed the experiments: KK LM. Analyzed the data: KK SE HR. Contributed reagents/materials/analysis tools: SW HR. Wrote the paper: KK HR SE.","Staffan Eriksson is a co-inventor of a TK1 activity patent licensed to DiaSorin Inc (METHOD FOR DETERMINATION OF THYMIDINE KINASE 1 ACTIVITY AND THE USE THERE OF and Publication number: WO2004013630 A1) and a co- founder, shareholder, board member and consultant to the company AroCell AB, Uppsala, which is developing an ELISA based on similar principles as described here but one different antibody for determination of human serum TK1 (see http://www.arocell.com). AroCell provided the monoclonal antibody as well as the serum dilution buffer used in the present study but have no influence on the design and performance of the work presented in this manuscript. There are no further patents, products in development or marketed products for veterinary use to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","09","Kiran Kumar Jagarlamudi","KKJ",5,TRUE,3,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
